Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine
Award Notice Posted
- Solicitation number
- PHS2021-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Zymeron Corporation
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93021C00025 Federal contract award
- Place of performance
- Durham, North Carolina 27709, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Zymeron Corporation was awarded a contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to develop an Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine. Under the $300,000 contract, Zymeron will utilize virus-mimicking nanoparticles combined with an adjuvant to enhance the immune response in their work developing an HIV vaccine for the agency over the coming year, as specified in the award notice published on September 23, 2021 under a total small business set aside.
Notice text
Awarded contract 75N93021C00025 to Zymeron Corporation for 300000.00 on 2021-07-01.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity